000			02192 a2200613 4500
005			20250513190110.0
264		0	_c19991021
008			199910s 0 0 spa d
022			_a0556-6177
040			_aNLM _beng _cNLM
100	1		_aSalgado, J E
245	0	0	_a[Intensive chemotherapy in the treatment of patients with metastatic breast cancer]. _h[electronic resource]
260			_bRevista de medicina de la Universidad de Navarra _c
300			_a143-51 p. _bdigital
500			_aPublication Type: English Abstract; Journal Article
650	0	4	_aAcute Kidney Injury _xchemically induced
650	0	4	_aAdult
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects
650	0	4	_aBone Marrow Diseases _xchemically induced
650	0	4	_aBreast Neoplasms _xdrug therapy
650	0	4	_aCarboplatin _xadministration & dosage
650	0	4	_aCarcinoma, Ductal, Breast _xdrug therapy
650	0	4	_aCombined Modality Therapy
650	0	4	_aCyclophosphamide _xadministration & dosage
650	0	4	_aDisease Progression
650	0	4	_aDisease-Free Survival
650	0	4	_aEtoposide _xadministration & dosage
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aHematopoietic Stem Cell Transplantation _xadverse effects
650	0	4	_aHepatic Veno-Occlusive Disease _xchemically induced
650	0	4	_aHumans
650	0	4	_aLife Tables
650	0	4	_aMiddle Aged
650	0	4	_aMitoxantrone _xadministration & dosage
650	0	4	_aNeoplasm Metastasis _xdrug therapy
650	0	4	_aNeoplasms, Hormone-Dependent _xdrug therapy
650	0	4	_aRadiotherapy, Adjuvant
650	0	4	_aRemission Induction
650	0	4	_aSalvage Therapy
650	0	4	_aSepsis _xetiology
650	0	4	_aShock, Cardiogenic _xetiology
650	0	4	_aSurvival Rate
650	0	4	_aThiotepa _xadministration & dosage
650	0	4	_aTreatment Outcome
700	1		_aAramendía, J M
700	1		_aFernández-Hidalgo, O A
700	1		_aLozano, E
700	1		_aRebollo, J
700	1		_aMartínez-Monge, R
700	1		_aSubirá, M L
700	1		_aBrugarolas, A
773	0		_tRevista de medicina de la Universidad de Navarra _gvol. 41 _gno. 3 _gp. 143-51
999			_c10378894 _d10378894